Search results
Startup led by former J&J executives raises $165M for cancer, immune disease drugs
BioPharma Dive· 7 days agoDrugmakers are also actively investigating whether CAR-T cell therapies, already established as...
Drugmakers are also actively investigating whether CAR-T cell therapies, already established as...